Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:34 pm Purchase | 13G | TG THERAPEUTICS, INC. TGTX | RA CAPITAL MANAGEMENT L.P. | 9,880,323 9.4% | 1,681,986 (+20.52%) | View |
| 2020-02-14 4:34 pm Sale | 13G | MYOVANT SCIENCES LTD COM MYOV | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,711,549 (Position Closed) | View |
| 2020-02-14 4:34 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | RA CAPITAL MANAGEMENT L.P. | 1,648,485 9.9% | 1,648,485 (New Position) | View |
| 2020-02-14 4:34 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -10,660,349 (Position Closed) | View |
| 2020-02-05 5:21 pm Purchase | 13D | BLACK DIAMOND THERAPEUTICS INC BDTX | RA CAPITAL MANAGEMENT L.P. | 2,589,904 7.2% | 2,589,904 (New Position) | View |
| 2019-11-13 5:05 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 3,161,214 26.2% | 3,161,214 (New Position) | View |
| 2019-11-08 5:26 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,646,646 12.6% | 3,646,646 (New Position) | View |
| 2019-10-18 5:04 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,422,312 12.7% | 3,471,980 (+178.02%) | View |
| 2019-10-11 4:12 pm Purchase | 13D | RA PHARMACEUTICALS INC RARX | RA CAPITAL MANAGEMENT L.P. | 4,858,260 10.3% | 1,006,452 (+26.13%) | View |
| 2019-09-17 4:54 pm Purchase | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA CAPITAL MANAGEMENT L.P. | 4,681,858 28.2% | 4,681,858 (New Position) | View |
| 2019-07-30 5:19 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 4,571,164 9.9% | 1,881,720 (+69.97%) | View |
| 2019-07-10 4:31 pm Sale | 13G | INFLARX N V COM IFRX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,810,708 (Position Closed) | View |